Atezolizumab versus chemotherapy in patients with platinum-treated locally advanced or metastatic urothelial carcinoma (IMvigor211): a multicentre, open-label, phase 3 randomised controlled trial
Titel:
Atezolizumab versus chemotherapy in patients with platinum-treated locally advanced or metastatic urothelial carcinoma (IMvigor211): a multicentre, open-label, phase 3 randomised controlled trial
Auteur:
Powles, Thomas Durán, Ignacio van der Heijden, Michiel S Loriot, Yohann Vogelzang, Nicholas J De Giorgi, Ugo Oudard, Stéphane Retz, Margitta M Castellano, Daniel Bamias, Aristotelis Fléchon, Aude Gravis, Gwenaëlle Hussain, Syed Takano, Toshimi Leng, Ning Kadel III, Edward E Banchereau, Romain Hegde, Priti S Mariathasan, Sanjeev Cui, Na Shen, Xiaodong Derleth, Christina L Green, Marjorie C Ravaud, Alain